alexa Rongyuan Zhuang
ISSN: 2167-7700

Chemotherapy: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Rongyuan Zhuang

 Medical Oncology Department, Zhongshan Hospital, Fudan University,  Shanghai, China

 Rongyuan Zhuang is currently working at Medical Oncology Department, Zhongshan Hospital, Fudan University, Shanghai, China. He has extended his valuable service as oncologist has been a recipient of many award and grants. His international experience includes various programs, contributions and participation in different countries for diverse fields of study. His research interests reflect in his wide range of publications in various national and international journals. 

Research Interest

 Chemotherapy; β-Tubulin; Docetaxel; Metastasis, cancer cell biology, molecular biology


β-Tubulin is a Predictive Marker of Docetaxel Combined with S-1 in Recurrent or Metastatic Gastric Cancer

Yuehong Cui, Rongyuan Zhuang, Qian Li, Shan Yu, Yiyi Yu, Yi Feng, Yan Wang, Xi Guo and Tianshu Liu

Research Article: Chemotherapy (Los Angel) 2014, 3: 132

Global Speakers in the subject

Global Experts in the subject

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version